Sees Q4 revenue $4.204B-$4.304B, consensus $4.24B. Sees Q4 adjusted EBITDA $1.033B-$1.058B. Comments taken from Q3 earnings conference call.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IQV:
- IQVIA Holdings: Hold Rating Amid Stable Performance and Limited Upside Potential
- Resilient Growth and Strong Segment Performance Drive Buy Rating for IQVIA Holdings
- Iqvia narrows FY25 adjusted EPS view to $11.85-$11.95 from $11.75-$12.05
- Iqvia reports Q3 adjusted EPS $3.00, consensus $2.98
- Cenobamate’s Real-World Impact: A New Hope for Focal Epilepsy?